Danny.
You can not be serious.This is the best biotech deal completed for the last 10 years .Not only the potential deal is us $335 million (approx$370 million aussie).The royalty stream at 20% is seriously big .Asuming axiron sell product for $500 million per year the royalty stream for acr is 100 million per year not a bad annuity i would have to say.Lets get the poorly informed sellers from bailleaus out the way and off to the races we go.
lilly to acquire global license to axiron, page-25
Add ACR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.8¢ |
Change
0.003(4.62%) |
Mkt cap ! $19.76M | |||
| Open | High | Low | Value | Volume |
| 6.8¢ | 6.8¢ | 6.8¢ | $4.266K | 62.74K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 6.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.7¢ | 47220 | 2 |
View Market Depth
| Last trade - 11.20am 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
6.6¢ |
Change
0.003 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 6.8¢ | 6.8¢ | 6.6¢ | 79400 | ||
| Last updated 14.23pm 24/05/2024 ? | |||||
| ACR (ASX) Chart |